Most recently, researchers reported the anti-tumor efficacy of a nanosystem delivering TLR7/8 agonist to target TAMs31, as well as successful reactivation of cytotoxic T cells to eliminate cancer cells by upregulating IL-12 p40 in macrophages32,33. This evidence concerns the gene TLR7 and cancer.